DJIA 18,126.12 -36.87 -0.20%
NASDAQ 5,097.98 -8.62 -0.17%
S&P 500 2,120.79 -2.69 -0.13%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

66.71 -1.01 (-1.49%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $66.71 -1.49%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.14
Previous Close $67.72
Daily Range $65.79 - $67.66
52-Week Range $26.57 - $77.80
Market Cap $8.0B
P/E Ratio -338.60
Dividend (Yield) $0.00 (0.0%)
Volume 1,536,801
Average Daily Volume 2,266,054
Current FY EPS -$0.37




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

Can Isis Pharmaceuticals (ISIS) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

IWM, GDJJ: Big ETF Outflows

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

IWM, VGLT: Big ETF Inflows

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Just What Is Invested Capital Anyway?


4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Akers Biosciences (AKER) Q1 Earnings: What's in Store? - Analyst Blog

See More ISIS News...

ISIS's Top Competitors

ISIS $66.71 (-1.49%)
Current stock: ISIS
AMGN $157.35 (-1.93%)
Current stock: AMGN
GILD $112.85 (0.35%)
Current stock: GILD
BIIB $400.10 (-0.70%)
Current stock: BIIB